This inventor holds 3 USPTO granted patents. Top assignees: Cel-Sci Corporation, Medtest Systems, Inc.. Active years: 1991-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-2000
Title: Discovering Innovations by Inventor Donald A. Elliott
Introduction
Donald A. Elliott, an innovative inventor based in Bethesda, MD, has made significant contributions to the field of immunology with his groundbreaking inventions. With a total of three patents to his name, Elliott has focused on creating advancements in immunological reagents and vaccines.
Latest Patents
One of Elliott's notable patents is related to heterofunctional cellular immunological reagents. This invention comprises at least two T cell specific binding ligands that are covalently linked together. One of these ligands binds to a specific class or subclass of T cells, while the other is associated with an antigen related to a disease or its causative agent. This functionality plays a crucial role in designing targeted vaccines that leverage the body's immune response effectively.
Career Highlights
Throughout his career, Donald A. Elliott has worked with prominent companies in the biopharmaceutical sector, including Cel-Sci Corporation and Medtest Systems, Inc. His work at these organizations has supported his research and development endeavors, propelling innovations in vaccine technology and immunological therapies.
Collaborations
In his journey as an inventor, Elliott has collaborated with talented individuals, such as Daniel H. Zimmerman and Vinodhini Guruswamy. Working alongside such talented coworkers has undoubtedly enriched his innovation process and fostered a dynamic environment for developing cutting-edge solutions in immunology.
Conclusion
Donald A. Elliott continues to inspire with his contributions to the field of immunology, particularly through his recent patents focusing on heterofunctional cellular immunological reagents and vaccines. His work is a testament to the importance of innovation in addressing medical challenges and advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
